Evidence map›Paper›PMID 30104718›Full record

Trial reportBone marrow transplantation2019

High-dose chemotherapy and autologous stem cell transplantation in enteropathy-associated and other aggressive T-cell lymphomas: a UK NCRI/Cancer Research UK Phase II Study.

Elizabeth H Phillips, Michelle M Lannon, Andre Lopes, Humra Chadwick, Gail Jones, Michal Sieniawski, Andrew Davies, Katrina Wood, Laura Clifton-Hadley, Paul Smith and 3 more

Erratum issuedAbstract readClinical Trial, Phase IILetter
PubMed Publisher
In one paragraph

Trial report in Bone marrow transplantation, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

13 authors.

Elizabeth H PhillipsCancer Research UK and University College London Cancer Trials Centre, London, UK. b.phillips@ucl.ac.uk.
Michelle M LannonDepartment of Haematology, Freeman Hospital, Newcastle Upon Tyne, UK.
Andre LopesCancer Research UK and University College London Cancer Trials Centre, London, UK.
Humra ChadwickCancer Research UK and University College London Cancer Trials Centre, London, UK.
Gail JonesDepartment of Haematology, Freeman Hospital, Newcastle Upon Tyne, UK.
Michal SieniawskiSouth Tyneside District Hospital, South Shields, UK.
Andrew DaviesCancer Research UK Centre, Cancer Sciences Unit, University of Southampton, Faculty of Medicine, Southampton, UK.
Katrina WoodDepartment of Cellular Pathology, Royal Victoria Infirmary, Newcastle Upon Tyne, UK.
Laura Clifton-HadleyCancer Research UK and University College London Cancer Trials Centre, London, UK.
Paul SmithCancer Research UK and University College London Cancer Trials Centre, London, UK.
Anthony LawrieCancer Research UK and University College London Cancer Trials Centre, London, UK.
Nick ChadwickCancer Research UK and University College London Cancer Trials Centre, London, UK.
Anne L LennardDepartment of Haematology, Freeman Hospital, Newcastle Upon Tyne, UK.

Funding

Cancer Research UK (CRUK) C12372/A4755
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AdultAgedFemaleHematopoietic Stem Cell TransplantationHumansLymphoma, T-CellMaleMiddle AgedTransplantation, AutologousTransplantation ConditioningUnited Kingdom

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.